Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
27 studies found for:    " May 22, 2007":" June 22, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
" May 22, 2007":" June 22, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (27 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Phase 1 Safety Study of Two Experimental HIV Vaccines
Conditions: AIDS Vaccines;   HIV Infections;   HIV-1
Interventions: Drug: VRC-HIVADV027-00-VP;   Drug: VRC-HIVADV038-00-VP
2 Completed Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection;   HIV-1 Infection
Interventions: Procedure: Cheek cells sample;   Procedure: Blood sample
3 Completed Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine
Condition: HIV Infection
Intervention: Biological: tgAAC09
4 Completed
Has Results 		Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir
Condition: HIV Infections
Intervention: Drug: Buprenorphine, Tipranavir and ritonavir
5 Completed Microbicides Acceptability Among Sexually Active Young Women
Condition: HIV Infections
Intervention: Behavioral: Automated diary system
6 Completed Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: efavirenz;   Drug: nevirapine
7 Completed Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers
Condition: HIV Infections
Interventions: Biological: DNA-C;   Biological: NYVAC-C
8 Completed Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults
Condition: HIV Infections
Intervention: Biological: MRKAd5 HIV-1 gag/pol/nef
9 Unknown † RiSolubles™, the Soluble Fraction of Rice Bran for HIV-Infected Patients
Condition: HIV Infections
Intervention: Behavioral: rice based food supplement
10 Completed A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
Conditions: HIV Infections;   TB
Intervention: Biological: MVA 85A
11 Unknown † Engaging Care for HIV-Infected Adolescent Females.
Condition: HIV Infection
Intervention:
12 Completed Project HERMITAGE: HIV Prevention in Hospitalized Russian Drinkers
Condition: HIV Infections
Interventions: Behavioral: Individual and group HIV risk behavior counseling sessions;   Behavioral: health education and support group
13 Completed Effects of Creatine and Resistance Exercise Training in People With HIV Infection
Condition: HIV Infections
Interventions: Procedure: Use of creatine monohydrate (a dietary supplement);   Behavioral: Progressive resistance exercise training
14 Completed A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication
Conditions: HIV Infections;   Contraception;   Pharmacokinetics
Intervention: Drug: levonorgestrel, efavirenz
15 Completed An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
Conditions: HIV Infections;   HCV
Interventions: Drug: Albinterferon;   Drug: Ribavirin;   Drug: Albuferon
16 Completed Safety Study of IL-7 in HIV-infected Patients (Inspire)
Conditions: HIV Infections;   Lymphopenia
Intervention: Drug: CYT 107
17 Completed Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients
Condition: HIV Infections
Intervention: Biological: GenHevac B Pasteur
18 Completed Growth Hormone in the Treatment of HIV-Associated Wasting
Conditions: HIV Infections;   HIV Wasting Syndrome
Intervention: Drug: Somatropin; Recombinant human growth hormone (r hGH)
19 Completed
Has Results 		Multicenter, Safety Study Of Maraviroc
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infection
Intervention: Drug: Maraviroc
20 Withdrawn Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients
Condition: Human Immunodeficiency Virus
Intervention: Drug: CP-675,206
To Top

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
† Indicates status has not been verified in more than two years